REGN

REGN

Regeneron Pharmaceuticals Inc
Biotechnology
$828.50 -0.67% As of Aug 25, 12:44 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

REGN Approaches Resistance Overbought at $828.50

Bearish
Aug 25, 2026 at 12:44 AM • $828.50 (-0.67%)

The stock of Regeneron Pharmaceuticals Inc (REGN) dropped 0.67% to close at $828.50 on August 25.

Technical indicators paint a mixed picture:

Moving Averages Moving averages are stacked bullishly—9-day EMA ($816.04) supports, 21-day ($781.29) below.
Momentum RSI at 74.1 is elevated in overbought zone, which often precedes pullbacks. MACD is bullish (38.48 vs signal 37.50).
Volatility Bollinger Band width at 20.5% indicates normal volatility.

While the trend remains bullish, elevated RSI warrants caution for new entries at current levels.

Key levels to watch: Support at $704.37, Resistance at $865.15.

Profit-Taking Watch: REGN Reaches $828.50 on High RSI

Bearish
Aug 24, 2026 at 9:02 PM • $828.50 (-0.67%)

Sell Signal? REGN RSI Peaks at $834.04

Bearish
Aug 23, 2026 at 8:32 AM • $834.04 (+0.90%)

REGN Overbought Surge to $834.04 May Stall

Bearish
Aug 22, 2026 at 12:23 AM • $834.04 (+0.90%)

REGN Enters Danger Zone as RSI Spikes at $834.04

Bearish
Aug 21, 2026 at 9:02 PM • $834.04 (+0.90%)
Systematic technical analysis • Updated daily after market close
Exclusive Offer

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Use code:
HEADSTART50
50% off your first month
Claim Offer Try Scanner

Market Summary

Current Price $828.50
Daily Change -0.67%
Sentiment Bearish
Sector Biotechnology
Last Updated Aug 25

Related Stocks

ABBV
ABBV
AbbVie Inc
AMGN
AMGN
Amgen Inc
BIIB
BIIB
Biogen Inc
MRNA
MRNA
Moderna Inc
VRTX
VRTX
Vertex Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.